Form 4: Alignment Healthcare CFO Sells 30,500 Shares Under 10b5-1 Plan

Alignment Healthcare's Chief Financial Officer, Robert Thomas Freeman, sold 30,500 shares of common stock at a price of $13.4215 per share on November 11, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Robert Thomas Freeman, the Chief Financial Officer of Alignment Healthcare, sold 30,500 shares of the company's common stock on November 11, 2024.
• The sale was executed at a price of $13.4215 per share.
• This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 15, 2024.
• Following the transaction, Mr. Freeman directly owns 865,407 shares and indirectly owns 92,929 shares through FCO Holdings LLC.
• The indirect ownership is held through FCO Holdings LLC, which is owned by FCO Holdings Trust One, an irrevocable trust where Mr. Freeman is an indirect beneficiary.

Sentiment

Score: 5

Explanation: The document reflects a routine insider transaction under a pre-arranged plan, which is neither positive nor negative in itself. The sentiment is neutral.

Risks

• Insider selling, even under a pre-arranged plan, can sometimes be perceived negatively by the market.

Industry Context

This is a routine disclosure of an insider transaction, which is common for publicly traded companies. The use of a 10b5-1 plan indicates the sale was pre-planned and not based on any recent material non-public information.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies to avoid accusations of insider trading.
• Similar filings are regularly made by executives at companies like UnitedHealth Group (UNH), Humana (HUM), and CVS Health (CVS) when they execute pre-planned stock sales.

Stakeholder Impact

• The sale may have a minor impact on shareholder sentiment, but it is unlikely to have a significant effect given the pre-planned nature of the transaction.

Key Dates

Keywords

insider trading, Form 4, 10b5-1 plan, stock sale, executive transaction, Alignment Healthcare, ALHC, Robert Thomas Freeman, CFO